ABSTRACT
We report the antibiofilm activity by the sponge-associated bacterium Cobetia marina upon Staphylococcus epidermidis clinical isolates obtained from central venous catheters. Antibiofilm activity/antimicrobial susceptibility correlation might predict the action of the metabolite(s) upon Staphylococcus epidermidis in the clinic, making it a possible adjuvant in therapies against biofilm-associated infections.
Subject(s)
Humans , Anti-Bacterial Agents/isolation & purification , Biofilms , Biotransformation , Disease Susceptibility , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/isolation & purification , Staphylococcal Infections , Staphylococcus epidermidis/growth & development , Staphylococcus epidermidis/isolation & purification , Methods , Patients , Methods , VirulenceABSTRACT
We report the antibiofilm activity by the sponge-associated bacterium Cobetia marina upon Staphylococcus epidermidis clinical isolates obtained from central venous catheters. Antibiofilm activity/antimicrobial susceptibility correlation might predict the action of the metabolite(s) upon Staphylococcus epidermidis in the clinic, making it a possible adjuvant in therapies against biofilm-associated infections.